Do Adolescents with Gynecomastia Require Routine Evaluation by Endocrinology?

Boccara, David; Ferrero, Lauren; Dutot, Marie Charlotte; Chaouat, Marc; Mimoun, Maurice; Serror, Kevin

doi:10.1097/prs.0000000000005335

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most patients did not have a hormonal study. As Malhotra et al and Boccara et al have pointed out, routine hormonal studies in all gynecomastia patients are not cost-effective and do not significantly alter treatment outcomes (Boccara et al., 2019; Malhotra, Amed, Bucevska, Bush, & Arneja, 2018). So evaluation of the effect of finasteride on the hormonal status of patients before and after the surgery was unobtainable.…”

Section: Discussionmentioning

confidence: 99%

Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia

Lee¹,

Park

Lee³

et al. 2019

Am J Mens Health

View full text Add to dashboard Cite

Finasteride is commonly used for treatment of alopecia. Because finasteride is a cause of gynecomastia, there is concern regarding the continuation of finasteride therapy after mastectomy. No studies have been performed to determine whether finasteride should be continued after mastectomy when gynecomastia occurs in patients taking finasteride for the treatment of alopecia. The researchers studied the effects of finasteride on gynecomastia recurrence after mastectomy in men with gynecomastia taking finasteride for alopecia. The researchers retrospectively evaluated 1,673 patients with gynecomastia who underwent subcutaneous mastectomy with liposuction at Damsoyu Hospital from January 2014 to December 2016. In total, 52 of the patients were taking finasteride for alopecia before surgery and continued to use it in the same manner after mastectomy. Ultrasonography was performed 1 year after mastectomy. The patients’ median age was 26.5 (24.75–30) years. All 52 patients had bilateral gynecomastia. The median duration of finasteride therapy before and after surgery was 12 (5–25.75) and 33 (27.5–40.5) months, respectively. There were no statistically significant differences between the groups with and without the use of finasteride in relation to postoperative complications and recurrence rates. Taking finasteride seems to have little effect on recurrence in patients with alopecia who have undergone surgical treatment of gynecomastia. Surgeons may recommend continuous finasteride therapy in patients with alopecia who wish to take finasteride after mastectomy.

show abstract

Section: Discussionmentioning

confidence: 99%